We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Fine Highlights Cost of Off-Label Lawsuits
Novartis Fine Highlights Cost of Off-Label Lawsuits
January 29, 2010
Novartis may pay $185 million to settle criminal allegations that it promoted an epilepsy drug for off-label use.